polyglycoplex
Botanicalexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
5
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00801814)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- polyglycoplex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01644201 | Phase 3 | Oct 1, 2012 | InovoBiologic Inc. |
| NCT01109199 | Phase 3 | Aug 1, 2010 | Canadian Center for Functional Medicine, InovoBiologic Inc., University of British Columbia |
| NCT01108328 | Phase 3 | Jun 1, 2010 | Canadian Center for Functional Medicine, InovoBiologic Inc., University of British Columbia |
| NCT00935350 | Phase 2/Phase 3 (Phase 3) | May 1, 2006 | Canadian Center for Functional Medicine, Glycemic Index Laboratories, Inc, InovoBiologic Inc. |
| NCT00801814 | Phase 2/Phase 3 (Phase 3) | Apr 1, 2006 | Canadian Center for Functional Medicine, Glycemic Index Laboratories, Inc, InovoBiologic Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| InovoBiologic Inc. | For profit | 5 | 1 | 1 | 2006 |
| Canadian Center for Functional Medicine | Academic/Hospital | 4 | 2 | 1 | 2006 |
| Glycemic Index Laboratories, Inc | For profit | 2 | 2 | 1 | 2006 |
| University of British Columbia | Academic/Hospital | 2 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1